BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetic studies in increased reactivity to phenprocoumon (Marcumar)]. 1973

H W Chriske, and P von Smekal, and M Knabe, and D Kray

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001593 Benzyl Compounds Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R. Compounds, Benzyl
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
February 1980, MMW, Munchener medizinische Wochenschrift,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
Proceedings: Binding properties of phenprocoumon (Marcumar) to human blood.
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Attempted murder with phenprocoumon (marcumar)(author's transl)].
September 1975, Deutsche medizinische Wochenschrift (1946),
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man].
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Peculiarities in the treatment of dialysis patients using phenprocoumon (Marcumar)].
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.
September 1976, Clinical pharmacology and therapeutics,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
Proceedings: Determination of phenprocoumon (Marcumar R) by gas-liquid-chromatography.
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
June 1976, International journal of clinical pharmacology and biopharmacy,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H W Chriske, and P von Smekal, and M Knabe, and D Kray
[The reciprocal actions of phenprocoumon (Marcumar) with human serum albumin, erythrocytes and blood].
December 1975, International journal of clinical pharmacology and biopharmacy,
Copied contents to your clipboard!